about
Triggering cell death by nanographene oxide mediated hyperthermia.Composite biomaterials based on ceramic polymers. I. Reinforced systems based on Al2O3/PMMA/PLLA.Mesoporous materials for drug delivery.Promising trends of bioceramics in the biomaterials field.Drug delivery from ordered mesoporous matrices.Sol-gel silica-based biomaterials and bone tissue regeneration.Nano-graphene oxide: a potential multifunctional platform for cancer therapy.The relevance of biomaterials to the prevention and treatment of osteoporosis.Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery.Mesoporous Silica Nanoparticles Decorated with Carbosilane Dendrons as New Non-viral Oligonucleotide Delivery Carriers.Targeted mesoporous silica nanocarriers in oncology.Response of osteoblasts and preosteoblasts to calcium deficient and Si substituted hydroxyapatites treated at different temperatures.Fabrication of novel Si-doped hydroxyapatite/gelatine scaffolds by rapid prototyping for drug delivery and bone regeneration.In vitro evaluation of graphene oxide nanosheets on immune function.Early in vitro response of macrophages and T lymphocytes to nanocrystalline hydroxyapatites.A unified in vitro evaluation for apatite-forming ability of bioactive glasses and their variants.Recent applications of the combination of mesoporous silica nanoparticles with nucleic acids: development of bioresponsive devices, carriers and sensors.Evaluation of the in vitro biocompatibility of PMMA/high-load HA/carbon nanostructures bone cement formulations.Improving catalase-based propelled motor endurance by enzyme encapsulation.L929 fibroblast and Saos-2 osteoblast response to hydroxyapatite-betaTCP/agarose biomaterial.In vitro positive biocompatibility evaluation of glass-glass ceramic thermoseeds for hyperthermic treatment of bone tumors.Glass-glass ceramic thermoseeds for hyperthermic treatment of bone tumors.Crystallochemistry, textural properties, and in vitro biocompatibility of different silicon-doped calcium phosphates.3D scaffold with effective multidrug sequential release against bacteria biofilm.Silica materials for medical applications.Nitric oxide production by endothelial cells derived from blood progenitors cultured on NaOH-treated polycaprolactone films: A biofunctionality study.Endothelial cells derived from circulating progenitors as an effective source to functional endothelialization of NaOH-treated poly(epsilon-caprolactone) films.Parathyroid hormone-related protein (107-111) improves the bone regeneration potential of gelatin-glutaraldehyde biopolymer-coated hydroxyapatite.Osteostatin-loaded bioceramics stimulate osteoblastic growth and differentiation.Surface electrochemistry of mesoporous silicas as a key factor in the design of tailored delivery devices.A bioactive sol-gel glass implant for in vivo gentamicin release. Experimental model in Rabbit.Incorporation of antimicrobial compounds in mesoporous silica film monolith.Tailoring vancomycin release from beta-TCP/agarose scaffolds.Electrical stimuli to increase cell proliferation on carbon nanotubes/mesoporous silica composites for drug delivery.In-vivo behavior of Si-hydroxyapatite/polycaprolactone/DMB scaffolds fabricated by 3D printing.Multifunctional pH sensitive 3D scaffolds for treatment and prevention of bone infection.A novel visible light responsive nanosystem for cancer treatment.Magnetic structure and electronic study of complex oxygen-deficient manganites.Effects of bleaching on osteoclast activity and their modulation by osteostatin and fibroblast growth factor 2.L-Trp adsorption into silica mesoporous materials to promote bone formation.
P50
Q35068899-6A63730E-4C02-4120-9380-64E3646300BFQ36824488-2D29E354-635C-4B15-9021-91F202C75162Q36939951-4B4870F9-A4C9-4F41-81AA-E172C653C44EQ37318902-B77CAF4C-F6B9-4BBB-8D3B-C483621B212AQ37639315-F13CE48B-C311-44EC-8EC0-6D03E24785A3Q37691719-9874CBB3-F46B-49E8-BC16-4C4B89AE47A6Q38092811-6F743862-55DE-48A5-B2EE-E728460FAEBDQ38177977-27BBC6B3-FB27-44AC-A6CE-371FC51BB364Q38271137-A312409B-1520-4C9C-9B52-FDE16DB3446FQ38296554-CD79C30C-C3F6-4C9B-8C9C-56A862AD0DF9Q38854861-349D352B-DE20-430D-94D5-75E23A2AF10CQ38858773-DA8E3CBC-10CE-4A32-9EFC-DC53C2084FC3Q38923029-E57C6B4B-22F7-4730-9FA6-CBC7DDB688D4Q38969313-00EB33A8-1ED6-4B4D-836D-5643B3833FA0Q39039733-7A33EB3B-7C2C-48B2-9D73-C702F5FD630FQ39041605-ED2E620B-943F-47F1-AF05-5B7929853A9CQ39096024-2F49A38F-9134-4A60-B5FC-09147CBFDDCFQ39107412-C742C3F6-43A3-41B8-AF45-5497767462CFQ39169977-7E9EB78C-5ECC-450C-8EB3-6BA37FA12620Q39988167-925FFF51-BB8F-4256-9DEF-D4DF33794B25Q39993692-9C43B559-279E-41B1-9B40-A2DB1FBA1F2EQ40264732-8EBFE920-BF03-404F-8461-257737043E0FQ40273141-ED5B231D-BB5E-46E9-98B7-678A6861C9C2Q40451795-3C21DE50-660E-4599-BEC0-D5BCBA83FEABQ42073501-809A31C3-EF0D-4A7A-9A36-570FE78C7B64Q42451580-9885778B-A637-43C2-AD47-7950D22E8D5CQ42524491-45BFA67F-F7E5-4415-AF1A-4BE973401EF7Q42804447-D1A6AD14-5DA9-47F5-9958-FA4C52250D98Q42834360-0936B0FC-C6AA-4F3B-979E-AF92F32EBD34Q43133593-E70A4F79-7E54-44B9-A386-77675D82B71BQ44226868-FF84D7A0-D750-49A4-B880-B259553F6343Q45921652-F4809B73-57C5-4041-A3D4-D0E424EF86ECQ45985493-0E7BDFE0-3B3F-4005-976E-32F43FF38980Q46064284-7BBE5E5E-16FF-4427-8DAB-C37A1EB5F3A6Q46135332-562DC8F3-9AFB-4684-9EF8-A44085709C79Q46263650-D2768F84-F04D-4609-9E68-FC98F08174B3Q46289124-C0721020-037B-4DBD-8760-6E55245020DCQ46439265-BC0C6DA6-E542-4BD3-86DA-531BC91158E7Q46664101-B307D252-3707-4BB3-B3EA-B37FC6CFDB66Q46782436-06FB54B1-167F-46EC-99E7-75507C41E9F8
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
M Vallet-Regí
@ast
M Vallet-Regí
@en
M Vallet-Regí
@es
M Vallet-Regí
@nl
type
label
M Vallet-Regí
@ast
M Vallet-Regí
@en
M Vallet-Regí
@es
M Vallet-Regí
@nl
prefLabel
M Vallet-Regí
@ast
M Vallet-Regí
@en
M Vallet-Regí
@es
M Vallet-Regí
@nl
P106
P31
P496
0000-0002-6104-4889